Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...

Explore stroke and preeclampsia treatment advancements with DiaMedica's lead drug candidate DM199 and its impact on vascular ...

The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has sought major ...

Parkinson’s disease (PD) remains one of the most challenging neurodegenerative disorders to diagnose and monitor.

Ted Jin, founder and CEO of AuX Labs, is leading a charge in the food technology space with a mission driven by global impact ...

GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 c ...

We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...

By measuring how proteins change in response to thousands of perturbations, nELISA complements transcriptomic data with a direct, functional readout of immune regulation-moving proteomic screening ...

By measuring how proteins change in response to thousands of perturbations, nELISA complements transcriptomic data with a direct, functional readout of immune regulation--moving proteomic screening ...

This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping ...

Third Quarter 2025 Financial Results Vaxart will provide a business update and report financial results for the third quarter ended September 30, 2025, after the market close on Thursday, November 13, ...

The designation may provide Leukogene with development incentives, including US market exclusivity and tax credits.